Torgersen J, Newcomb CW, Carbonari DM, Rentsch CT, et al. Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation. J Hepatol 2021 Jul 29. pii: S0168-8278(21)01950.
PMID: 34333102